Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toronto BioScience is a private Canadian life science company that develops, manufactures, and sells diagnostic and research-use products rather than therapeutics. Its portfolio includes ELISA kits, immunoturbidimetric assay kits, antibodies, recombinant proteins, COVID-19 antigen and serology products, and related custom services for academic, clinical, and research customers. The company focuses on biomarker and assay products spanning diabetes, obesity, cardiovascular, autoimmune, inflammatory, oncology, and infectious disease applications. Toronto BioScience also markets consulting, sample analysis, custom antibody work, and Olink proteomics-related services. It appears to operate commercially as a niche research tools and diagnostics supplier based in Toronto, in close partnership with ImmunoDiagnostics Ltd.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toronto BioScience.